Abstract ObjectiveTo study the expression and role of cyclic-AMP response binding protein (CREB) and Bcl-2 in children with acute leukemia. METHODS: Ninety-two children with acute leukemia (leukemia group) and 30 children with non-hematologic malignancies (control group) were enrolled. The mRNA and protein expression of CREB and Bcl-2 in bone marrow mononuclear cells were measured by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot. RESULTS: The mRNA and protein expression of CREB and Bcl-2 in the leukemia group was significantly higher than that in the control group (P<0.01). There were no significant differences in the expression of CREB and Bcl-2 between acute lymphoblastic leukemia and acute myeloid leukemia subgroups. At the initial diagnosis, the mRNA and protein expression of CREB and Bcl-2 in children with extramedullary infiltration was higher than that in children without (P<0.05). In the leukemia group, the mRNA and protein expression of CREB and Bcl-2 in the complete remission subgroup was significantly lower than that in the non-complete remission subgroup (P<0.01). High mRNA expression of CREB and Bcl-2 in the leukemia group was positively correlated with peripheral blood leucocyte counts (r=0.62, 0.71 respectively, P<0.05). There was a positive correlation between mRNA and protein expression of CREB and Bcl-2 (r=0.75, 0.68 respectively; P<0.05). CONCLUSIONS: The expression of CREB and Bcl-2 may be correlated with the pathogenesis and clinical prognosis of childhood leukemia, however, their expression may not be associated with the classification of acute leukemia.［Chin J Contemp Pediatr, 2010, 12 (3):177-180］
WEN Chuan,MA Fu-Tian,WAN Wu-Qing. Expression of CREB/Bcl-2 in bone marrow mononuclear cells of children with acute leukemia[J]. 中国当代儿科杂志, 2010, 12(3): 177-180.
WEN Chuan,MA Fu-Tian,WAN Wu-Qing. Expression of CREB/Bcl-2 in bone marrow mononuclear cells of children with acute leukemia[J]. CJCP, 2010, 12(3): 177-180.
［3］Shankar DB, Cheng JC, Sakamoto KM. Role of cyclic AMP response element binding protein in human leukemias［J］. Cancer, 2005, 104(9):1819-1824.
［4］Siu YT, Jin DY. CREB—a real culprit in oncogenesis［J］. FEBS J, 2007, 274(13):3224-3232.
［5］Cheng JC, Esparza S, Sandoval S,Shankar D, Fu C, Sakamoto KM. Potential role of CREB as a prognostic marker in acute myeloid leukemia［J］. Future Oncol, 2007, 3(4):475-480.
［6］Orelio C, Dzierzak E. Bcl-2 expression and apoptosis in the regulation of hematopoietic stem cells［J］. Leuk Lymphoma, 2007, 48(1):16-24.
［7］Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy［J］. Cell Death Differ, 2009, 16(3):360-367.
［8］Tabe Y. Molecular diagnosis of and molecular targeting therapy for leukemia［J］. Rinsho Byori, 2009, 57(2):137-145.
［9］Fulda S. Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia［J］. Br J Haematol, 2009, 145(4):441-454.
［10］Schuler D, Szende B. Apoptosis in acute leukemia［J］. Leuk Res, 2004, 28(7):661-666.
［11］Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM. Expression of cyclic adenosine monophosphate responseelement binding protein in acute leukemia［J］. Blood, 2002, 99(7):2617-2619.
［12］Pigazzi M, Ricotti E, Germano G, Faggian D, Aricò M, Basso G. cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression［J］. Haematologica, 2007, 92(10):1435-1437.
［13］Moon JH, Sohn SK, Lee MH, Jang JH, Kim K, Jung CW, et al. BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients［J］. Leuk Res, 2010, 34(2):166-172.
［14］Zhang CY, Wu YL, Boxer LM. Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells［J］. J Biol Chem, 2002, 277(50):48359-48365.
［15］Joo EK, Broxmeyer HE, Kwon HJ, Kang HB, Kim JS, Lim JS, et al. Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e［J］. Stem Cells Dev, 2004, 13(5):563-570.
［16］Swart JM, Bergeron DM, Chiles TC. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulate cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas［J］. J Immunol, 2000, 164(5):2311-2319.
［17］Aucoin R, Reiland J, Roy M, Marchetti D. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion［J］. J Cell Biochem, 2004, 93(2):215-223.
